Fox Chase Cancer Center is offering advanced cancer patients a clinical test that will provide them with a blueprint of their cancer genes. The new clinical test, known as CancerCode-45TM, evaluates an individual's tumor for genetic alterations in a select group of 45 genes and gives physicians the opportunity to look at the alterations and be even more precise when choosing a course of treatment. The test is being offered through the Cancer Genome Institute ...Sunday, 6 January 2013
Clinical Blueprint of Cancer Genes
Fox Chase Cancer Center is offering advanced cancer patients a clinical test that will provide them with a blueprint of their cancer genes. The new clinical test, known as CancerCode-45TM, evaluates an individual's tumor for genetic alterations in a select group of 45 genes and gives physicians the opportunity to look at the alterations and be even more precise when choosing a course of treatment. The test is being offered through the Cancer Genome Institute ...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment